Cardiolyse

Company profile

About Cardiolyse

Cardiolyse is a cloud-based ECG and heart rate variability (HRV) analytics platform that delivers medical-grade cardiac monitoring and predictive analytics for cardiovascular health. The company provides real-time remote heart health monitoring through integration with digital ECG devices, serving cardiologists, general practitioners, healthcare providers, and elevated-risk patient populations. The platform employs clinically proven machine learning algorithms to analyze up to 400 vital ECG parameters, detecting all types of arrhythmias, atrial fibrillation, myocardial infarction, and ventricular hypertrophy. Its patent-pending Universal ECG and Personal Baseline Scores enable prediction of heart attacks and strokes up to two months before they occur. The system generates personalized reports on vital cardiac parameters to guide medication adjustments and lifestyle modifications, increasing access to preventive care. Cardiolyse offers three primary solutions: remote real-time heart health monitoring for elevated risk groups, diabetes cardiovascular comorbidities prevention with specific cardiac parameter monitoring, and fatigue risk management for critical safety job performers. The platform is CE-certified and has analyzed over 3.2 million ECG recordings and 2.6 million HRV analyses, reportedly preventing 146 critical heart events. Founded by healthcare and cardiology experts with decades of combined experience, Cardiolyse aims to reduce healthcare system costs by preventing dangerous heart events and hospital readmissions through early detection and intervention.

Company description · Cardiolyse official website